AR017097A1 - COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS - Google Patents

COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS

Info

Publication number
AR017097A1
AR017097A1 ARP980104535A ARP980104535A AR017097A1 AR 017097 A1 AR017097 A1 AR 017097A1 AR P980104535 A ARP980104535 A AR P980104535A AR P980104535 A ARP980104535 A AR P980104535A AR 017097 A1 AR017097 A1 AR 017097A1
Authority
AR
Argentina
Prior art keywords
compounds
useful
pharmaceutical compositions
inhibitors
oxazolona
Prior art date
Application number
ARP980104535A
Other languages
Spanish (es)
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of AR017097A1 publication Critical patent/AR017097A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/38One oxygen atom attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Se trata de compuestos de 2-(3H)-oxazolona de formula (I) donde: r1 es alquilo o un grupo amino; R2 es naftilo, un grupo fenilo o fenilo no sustituido,sustituido desde 1 a 3 átomos de halogeno o alquilo, alcoxi o grupos trifluorometilo; y R3 es hidrogeno o un grupo alquilo. Dichos compuestos son utiles comoinhibidores selectivos de la COX-2 (ciclooxigenasa-2), utiles para el tratamiento de enfermedades mediadas por la COX-2, sin la manifestacion de efectosulcerogénicos. También se propone un procedimiento para preparar dichos compuestos de formula (I), y composiciones farmacéuticas que los incluyen como agenteactivo.These are 2- (3H) -oxazolone compounds of formula (I) where: r1 is alkyl or an amino group; R2 is naphthyl, an unsubstituted phenyl or phenyl group, substituted from 1 to 3 halogen or alkyl, alkoxy or trifluoromethyl groups; and R3 is hydrogen or an alkyl group. These compounds are useful as selective inhibitors of COX-2 (cyclooxygenase-2), useful for the treatment of diseases mediated by COX-2, without the manifestation of ulcer effects. A process is also proposed for preparing said compounds of formula (I), and pharmaceutical compositions that include them as active agent.

ARP980104535A 1997-09-12 1998-09-11 COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS AR017097A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701928A ES2131015B1 (en) 1997-09-12 1997-09-12 NEW DERIVATIVES OF 2- (3H) -OXAZOLONE, PROCEDURES FOR ITS PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS.

Publications (1)

Publication Number Publication Date
AR017097A1 true AR017097A1 (en) 2001-08-22

Family

ID=8300586

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104535A AR017097A1 (en) 1997-09-12 1998-09-11 COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS

Country Status (10)

Country Link
EP (1) EP1017685A1 (en)
JP (1) JP2001516750A (en)
AR (1) AR017097A1 (en)
AU (1) AU9623698A (en)
CO (1) CO5011110A1 (en)
ES (1) ES2131015B1 (en)
PE (1) PE116999A1 (en)
UY (1) UY25179A1 (en)
WO (1) WO1999014205A1 (en)
ZA (1) ZA988303B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
ES2166710B1 (en) * 2000-04-25 2004-10-16 J. URIACH & CIA, S.A. NEW HETEROCICLIC COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY.
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
ES2213485B1 (en) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. DERIVATIVES OF 2-FENILPIRAN-4-ONA.
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
EP0825989A1 (en) * 1995-05-19 1998-03-04 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
ES2125161B1 (en) * 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S NEW DERIVATIVES OF 2- (3H) -OXAZOLONA.
FR2753449B1 (en) * 1996-09-13 1998-12-04 Union Pharma Scient Appl NOVEL 3,4-DIARYLOXAZOLONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES

Also Published As

Publication number Publication date
EP1017685A1 (en) 2000-07-12
ZA988303B (en) 1999-03-11
AU9623698A (en) 1999-04-05
WO1999014205A1 (en) 1999-03-25
UY25179A1 (en) 2000-12-29
ES2131015B1 (en) 2000-03-01
PE116999A1 (en) 1999-12-13
JP2001516750A (en) 2001-10-02
ES2131015A1 (en) 1999-07-01
CO5011110A1 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
AR016762A1 (en) 4-BROMO OR 4-IODINE PHENYLAMINE BENZOHIDROXAMIC ACID COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USE OF THE SAME
ES2088933T3 (en) DERIVATIVES OF PIRAZOLE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
AR029301A1 (en) COMPOUNDS DERIVED FROM BIARILO, METHODS FOR THEIR PREPARATION COMPOSITIONS THAT CONTAIN THEM, THEIR USE AS AGONISTS IN BETA-ADRENO-ATIPIC RECEIVERS
AR006720A1 (en) A COMPOUND DERIVED FROM HETERO-CYCLIC AZAHEXANE, ITS USE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, PROCEDURE FOR PREPARING IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
AR005706A1 (en) EGFR INHIBITORS OF 4-AMINOQUINZOLINE, PROCEDURE FOR THEIR OBTAINING, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THE SAME FOR THE PREPARATION OF A MEDICINE USEFUL AS AN ANTINEOPLASTIC AGENT
DE60226875D1 (en) ORTHOSUBSTITUTED ARYLAMIDES FOR COMBATING WIRELESS PESTS
BR9307580A (en) Process compounds for the preparation of the same pharmaceutical compositions use of a compound and process for the treatment of a mammal that includes humans
ES2058089T3 (en) A PROCEDURE FOR THE PREPARATION OF A NEW PROLINAL DERIVATIVE.
BR0213646A (en) Method, compounds and composition for invertebrate pest control
AR002690A1 (en) DERIVATIVE OF BENCIMIDAZOLE OR SALTS OF THE SAME, PHARMACEUTICAL COMPOSITION, IMMUNOSUPPRESSIVE AGENT AND ANTI-INFLAMMATORY AGENT THAT CONTAIN IT AND PROCEDURES TO PREPARE SUCH DERIVATIVE.
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
AR002711A1 (en) A COMPOUND OF 2-CARBOXINDOL-3-SUBSTITUTED, A PROCESS FOR ITS PREPARATION, A NEW INTERMEDIATE COMPOUND FOR SUCH PROCESS, THE USE OF THE COMPOUND FOR THE MANUFACTURE OF A THERAPEUTIC AGENT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH A COMPOUND.
NO871861L (en) PROCEDURE FOR THE PREPARATION OF NEW DOPAMINE BETA-HYDROXYLASE INHIBITORS.
EA200100090A2 (en) New piperide-4-sulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
PE20021018A1 (en) DERIVATIVES OF ß - CARBOLINE
ES2151254T3 (en) 2- (3H) -OXAZOLONE DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS.
AR017097A1 (en) COMPOUNDS OF 2- (3H) -OXAZOLONA, USEFUL AS SELECTIVE COX-2 INHIBITORS; PROCEDURE TO PREPARE SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FORMED WITH SUCH COMPOUNDS
DK0875506T3 (en) Quinoline and quinazoline compounds useful for treatment
PT99465A (en) METHOD FOR PREPARING OXISULFONIL INHIBITORS UREIA ACIL-COA: CHOLESTEROL ACYL-TRANSFERASE (ACAT)
PE20001067A1 (en) DERIVATIVES OF 2-FENYLPYRAN-4-ONA
AR035247A1 (en) DERIVATIVES OF PIPERIDINACARBOXAMIDA, A PROCEDURE FOR ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR036028A1 (en) PIRIMIDINE COMPOUND, PROCEDURE FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS AND USE OF COMPOUNDS IN THE PREPARATION OF THE MENTIONED COMPOSITIONS
DK477783A (en) 1,3,4,6,7-11B-HEXAHYDRO-7-ARYL-2H-PYRAZINO (2,1-A) -ISOQUINOLINES, METHOD FOR PREPARING IT AND THEIR USE AS INTERMEDIATES AND MEDICINAL PRODUCTS
PT99360A (en) METHOD FOR THE PREPARATION OF OXY-SULFONYL CARBAMATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK333380A (en) METHOD OF PREPARING 3-AMINO-1-BENZOXEPINE DERIVATIVES OR ACID ADDITION SALTS.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal